C&Y Pharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 10.3904 million yuan, a decrease of 43.17%
I'm LongbridgeAI, I can summarize articles.C&Y Pharmaceutical released its Q1 2025 performance report, with operating revenue of 182 million yuan, a year-on-year decrease of 4.09%. The net profit attributable to the parent company was 10.3904 million yuan, a year-on-year decline of 43.17%; the net profit after deducting non-recurring gains and losses was 2.7904 million yuan, a year-on-year decrease of 82.48%. The basic earnings per share were 0.043 yuan
According to the Zhitong Finance APP, C&Y Pharmaceutical (300254.SZ) released its first-quarter report for 2025, showing an operating income of 182 million yuan, a year-on-year decrease of 4.09%. The net profit attributable to shareholders of the listed company was 10.3904 million yuan, a year-on-year decrease of 43.17%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 2.7904 million yuan, a year-on-year decrease of 82.48%. The basic earnings per share were 0.043 yuan